BRIEF-Shanghai Fosun pharmaceutical says unit entered into JV contract

April 27 (Reuters) - Shanghai Fosun Pharmaceutical Group Co


* Unit, Xingxin Investment, Fosun Golden entered into joint

venture contract

* Under joint venture contract, Fosun Pingyao, Xingxin

Investment And Fosun Golden agreed to establish new company

* Registered capital of new co is RMB500 million, fosun

pingyao, xingxin investment and fosun golden 20pct, 60pct and

20pct of equity interests respectively

* Business scope of new Co includes financial lease,

purchasing leased assets from domestic and -2- foreign markets

* Fosun Pingyao agreed to make capital contribution into new

company in amount of RMB100 million in cash

Source :(

Further company coverage: